We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of fibrosis and impact a broad range of fibrotic and related diseases, including cancer. Its initial focus is on the development of small-molecule inhibitor... Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of fibrosis and impact a broad range of fibrotic and related diseases, including cancer. Its initial focus is on the development of small-molecule inhibitors of galectin-3 and lysyl oxidase-like 2, or LOXL2. Its product candidate GB0139 is for the treatment of severe fibrotic lung diseases such as idiopathic pulmonary fibrosis, or IPF, a life-threatening progressive fibrotic disease of the lung. Its product GB1211, a selective oral galectin-3 inhibitor for the treatment of fibrosis related to non-alcoholic steatohepatitis, or NASH, and GB2064, a selective oral inhibitor of LOXL2 that it initially plans to develop for the treatment of myelofibrosis. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0099 | 1.43436685019 | 0.6902 | 0.74 | 0.68 | 122440 | 0.71342822 | CS |
4 | 0.0201 | 2.95588235294 | 0.68 | 0.74 | 0.6371 | 100117 | 0.69669276 | CS |
12 | -0.0199 | -2.76388888889 | 0.72 | 0.94 | 0.6 | 200186 | 0.76683969 | CS |
26 | 0.084 | 13.6341503003 | 0.6161 | 0.94 | 0.5353 | 274829 | 0.69026796 | CS |
52 | -1.3399 | -65.681372549 | 2.04 | 3.7 | 0.5 | 363167 | 0.96594408 | CS |
156 | -4.7499 | -87.1541284404 | 5.45 | 16.41 | 0.5 | 277736 | 3.09189958 | CS |
260 | -15.0699 | -95.5605580216 | 15.77 | 17.99 | 0.5 | 242406 | 3.27128094 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions